As such, using a recently introduced FAP-targeted PET agent initially developed for patients affected with oncological diseases, we investigated a large cancer cohort imaged with [68 Ga]Ga-FAPI-04 to perform an in-depth analysis of plaque burden with radiotracer accumulation in the arterial tree. This evidence concerns the gene FAP and cancer.